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Background: DiGeorge/velocardiofacial syndrome (DGS/VCFS) is the most common deletion syndrome in humans.
Low copy repeats flanking the 22q11.2 region confer a substrate for non-allelic homologous recombination (NAHR)
events leading to rearrangements. This study sought to identify DGS/VCFS fathers with increased susceptibility
to deletions and duplications at the 22q11.2 region in spermatozoa and to assess the particular contribution of
intra-chromatid and/or inter-chromatid NAHR. Semen samples from nine DGS/VCFS fathers were analyzed by
triple-color FISH using a probe combination that discriminated between normal, deleted and duplicated genotypes.
Microsatellite analysis were performed in the parents and the affected children to determine the parental origin of
the deleted chromosome 22.
Results: A significant increase in 22q11.2 deletions was observed in the sperm of two out of nine DGS/VCFS
fathers (odds ratio 2.03-fold, P < 0.01), and in both cases the deletion in the offspring was transmitted by the father.
Patients with significant increases in sperm anomalies presented a disturbed deletion:duplication 1:1 ratio (P < 0.01).
Conclusions: Altogether, results support that intra-chromatid NAHR is the mechanism responsible for the higher
rate of sperm deletions, which is directly related to the transmission of the deleted chromosome 22 to offspring.
Accordingly, the screening of sperm anomalies in the 22q11.2 region should be taken into account in the genetic
counseling of DGS/VCFS families.
Keywords: Deletions and duplications, DiGeorge/velocardiofacial syndrome, Non-allelic homologous
recombination, SpermatozoaBackground
Diseases caused by chromosomal rearrangements because
of architectural features of unstable regions are referred to
as genomic disorders [1]. Regions involved in genomic
disorders are flanked by low copy repeats (LCRs) [2]
which, due to high degree of homology between their
duplicated sequences (>95%), act as substrates for non-
allelic homologous recombination (NAHR) [3,4].
Depending on the LCRs orientation and the number
and type of chromatids involved, different rearrangements
of the intervening segments are formed (Figure 1A): com-
plementary deletions and duplications (inter-chromatid* Correspondence: joan.blanco@uab.cat
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LCRs), deletions and ring-acentric fragments (intra-
chromatid NAHR between directly oriented LCRs) or
inversions (intra-chromatid NAHR between indirectly
oriented LCRs) [5].
The pericentromeric area of chromosome 22 contains
eight distinct highly homologous LCRs comprising roughly
11% of the 22q11.2 region. According with their position in
relation to the centromere, LCR22 regions are desingated
as LCR22-2, LCR22-3a, LCR22-3b, LCR22-4, LCR22-5,
LCR22-6, LCR22-7 and LCR22-8 [6]. It has been reported
that these LCRs are involved in recurrent reorganiza-
tions causing different genomic disorders. Among them,
DiGeorge/velocardiofacial syndrome (DGS/VCFS) (OMIM
188400/OMIM 192430) is the most common deletion syn-
drome in humans with an incidence of 1:4000 newbornsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Genomic rearrangements in the DGS critical region. A Products of non-allelic homologous recombination (NAHR) between directly
oriented LCRs. B Representation of 22q11.2 region and the most frequent DGS/VCFS deletions (adapted from Babcock et al. [6]). Colored arrows
representative copies of the following genes and pseudogenes: USP18, GGTLA, GGT, IGSF3 and BCR.
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comprised within the 22q11.2 region.
More than 85% of DGS/VCFS cases are caused by
NAHR events involving LCR22-2 and LCR22-4 that give
rise to a 3 Mb deletion [8]. In around 7% of cases, there
are smaller deletions of 1.5 Mb flanked by LCR22-2 and
LCR22-3a. The remaining cases are caused by unusual
deletions involving distal LCR22s [9-11] (Figure 1B).
The duplication of the 22q11.2 region has been reported
to cause a different phenotypic spectrum (22q11.2 duplica-
tion syndrome; OMIM 608363). It is important to mention
that most of the duplications are the reciprocal prod-
ucts of 22q11.2 deletions originated by inter-chromatid
or inter-chromosomal NAHR [12] (Figure 1A). Due to
the milder phenotypes of duplications, which in some
cases remain unnoticed, they have been probably under-
diagnosed, thus compromising the estimation of their real
incidence [13,14].
Concerning recurrence, the risk of DGS/VCFS and
22q11.2 duplication syndrome appears to be negligible,
i.e. not different from the general population and has been
established to be less than 0.5% [15]. The few familial
cases described for DGS/VCFS have been related to a
potential, unproven, parental mosaicism for a deletion inone of the progenitors [16,17]. Nevertheless, in several
recurrent genomic disorders, some haplotypes have been
suggested to predispose to NAHR events. In this sense,
inversions of the critical regions have been reported in
the fathers of children affected by deletion syndromes:
Williams-Beuren [18-20], Prader-Willi [21], Angelman
[22], Smith-Magenis [23] and 17q21.31 microdeletion
[24], among several others [25]. In addition, copy number
variations in the LCRs which flank critical regions have
been described in fathers with affected offspring: Smith-
Magenis syndrome [26], Williams-Beuren syndrome [27]
or 16p12.1 microdeletion disease [28]. Moreover trans
regulator factors of meiotic recombination, such as
PRDM9, have also been associated with genomic disor-
ders. In particular, certain PRDM9 alleles have been
suggested to predispose NAHR events of the regions
17p11.2 (Charcot-Marie-Tooth disease type 1A and
hereditary neuropathy with liability to pressure palsies)
[29], 7q11.2 (Williams-Beuren syndrome) [30] and 22q11.2
(DGS/VCFS) [31]. Finally, it has been described in the
human germline an association between DNA hypomethy-
lation of the critical regions and NAHR mediated by LCRs,
suggesting the existence of an additional predisposing
factor to NAHR based on methylation variations [32].
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inter-chromosomal NAHR in DGS cases, in agreement
with previous observations by Edelmann et al. [34]. Simi-
larly, previous results from our group in control donors
showed no differences in the frequency of sperm 22q11.2
deletions and duplications, supporting inter-chromatid/
chromosomal NAHR as the predominant mechanism for
22q11.2 rearrangements [35] (Figure 1A).
Fluorescence in situ hybridization (FISH) based meth-
odologies in decondensed sperm nuclei allow the iden-
tification of gametes carrying deletions, duplications
and inversions with a high sensitivity and specificity
[21,35,36]. These interphase analyses, carried out in a
large number of spermatozoa, offers the possibility of
performing cell by cell analyses, thus assessing the
incidence of rare events such as NAHR, and to estab-
lish a direct relationship between the genomic archi-
tecture and chromosomal instability during meiosis.
Previous results from our group have pointed out an
increased incidence of 15q11q13 deletions in sperm-
atozoa from some Prader-Willi syndrome (PWS) fa-
thers, suggesting a higher risk of transmission of
deletions in these subjects [35].
The aim of the present study was to analyze the fre-
quency of deletions and duplications occurring at the
22q11.2 region in spermatozoa of fathers with descen-
dants affected by DGS/VCFS using sperm-FISH strategies.
The analysis of the results will allow us to assess whether
an increase in the susceptibility of generating deletions
and duplications is present in these subjects and to assess
the particular contribution of the intra-chromatid and/or
inter-chromatid NAHR events in the generation of these
anomalies.Table 1 Sperm-FISH results in the DGS fathers
Case Age Normal del 22q11.2
DG-1 39 10000 (99.19) 24 (0.24)
DG-2 48 10000 (98.40) 57 (0.57)*
DG-3 - 9927 (99.09) 19 (0.19)
DG-4 43 10000 (99.30) 15 (0.15)
DG-5 36 10096 (98.87) 52 (0.52)*
DG-6 30 10000 (99.24) 28 (0.28)
DG-7 39 10000 (99.34) 18 (0.18)
DG-8 33 9948 (99.31) 13 (0.13)
DG-9 37 9930 (98.59) 25 (0.25)
% ± SEM 99.04 ± 0.11 0.28 ± 0.05
% ± SEMb 99.08 ± 0.09 0.17 ± 0.02
aDisomies, diploidies and nullisomies.
bControl population data published in Molina et al., 2011 [36].
*Significant increases versus control data (P < 0.01).
Bold numbers indicate distortion of the 1:1 del:dup ratio (P < 0.01).Results
Deletion and duplication frequencies in the 22q11.2
region were analyzed in a total of 90,776 sperm nuclei
from nine fathers of DGS/VCFS individuals (Table 1).
The mean frequency of deletions (±SEM) was 0.28% ±
0.05, ranging from 0.13 to 0.57% and the mean frequency
of duplications (±SEM) was 0.11% ± 0.02, ranging from
0.05 to 0.20% (Table 1).
No significant differences were observed in the frequency
of deletions, duplications or del + dup between the popula-
tion of DGS/VCFS fathers and our internal control data
(Mann-Whitney test; P = 0.111, P = 1.000 and P = 0.191,
respectively). At the individual level, we found significant
increases in 22q11.2 deletions and del + dup in two out of
nine DGS/VCFS fathers (Chi-square test; DG-2 and DG-5
P < 0.01) (Figure 2, Table 1). The risk to generate deletions
of these individuals compared with the control population
was estimated with an odds ratio of 2.03 (95% CI =1.63-
2.54). On the other hand, there was no correlation between
the frequencies of deletions, duplications or del + dup and
the father’s age (Spearman correlation; P = 0.840, P = 0.360
and P = 0.752, respectively).
Concerning the participation of the inter-chromatid
and/or intra-chromatid NAHR in the generation of anom-
alies, no correlation was observed between deletion and
duplication frequencies in DGS/VCFS fathers (Spearman
correlation; P = 0.194). Furthermore, a significant increase
in the mean frequency of 22q11.2 deletions was observed
compared with the mean frequency of 22q11.2 duplica-
tions (Wilcoxon test; P = 0.004) (Figure 3). Individual
comparisons showed significant increases in 22q11.2 dele-
tions in three out of the nine cases analyzed (Chi-square
test; DG-2, DG-5 and DG-6 P < 0.01) (Table 1); DG2 anddup 22q11.2 del + dup Othersa Total
11 (0.11) 35 (0.35) 47 (0.47) 10082
20 (0.20) 77 (0.77)* 86 (0.86) 10163
13 (0.13) 32 (0.32) 59 (0.59) 10018
7 (0.07) 22 (0.22) 49 (0.49) 10071
12 (0.12) 64 (0.64)* 51 (0.51) 10211
5 (0.05) 33 (0.33) 43 (0.43) 10076
7 (0.07) 25 (0.25) 41 (0.41) 10066
10 (0.10) 23 (0.23) 46 (0.46) 10017
16 (0.16) 41 (0.41) 31 (0.31) 10072
0.11 ± 0.02 0.39 ± 0.06 0.50 ± 0.05
0.12 ± 0.03 0.27 ± 0.05 0.64 ± 0.05
Figure 2 Frequencies of 22q11.2 deletions and duplications observed in each DGS father. Asterisks indicate cases with significant increases in
deletions compared with control data (Molina et al. [36]). Dashed lines indicate deletion and duplication mean in controls (0.17 and 0.12, respectively).
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increases in 22q11.2 deletions and del + dup compared to
the control data.
The parental origin of the syndromes was ascertained
in eight out of the nine DGS/VCFS families. In six out
of the eight families, the origin of the deletion on
chromosome 22 was paternal. In the remaining two cases,
the origin was maternal (Table 2). Importantly, in the
fathers that showed significant increases in 22q11.2
deletions and del + dup in spermatozoa, the origin of
the deletion on chromosome 22 in the affected children
was paternal.
Discussion
The reliability of sperm-FISH analyses to detect deletions
and duplications has already been demonstrated in previous
studies [35,36]. The use of probes spanning the critical re-
gion, control probes for the chromosome involved and the
application of strict scoring criteria allow the unequivocal
identification of normal, deleted and duplicated genotypes.Figure 3 Mean frequencies of 22q11.2 deletions and duplications
in control donors (Molina et al. [36]) and DGS fathers. Error
bars represent the standard error of the mean (SEM) and asterisks
indicate significant differences between the frequency of deletions
and duplications.In the population of DGS/VCFS fathers, no increased
susceptibility in generating deletions and duplications
was observed. Nevertheless, we found significant increases
in sperm 22q11.2 deletions in two fathers who were
among the ones who transmitted the deletion on chromo-
some 22 to their offspring. Focusing on cases with a pater-
nally inherited deletion (n = 6; Table 2), two out of the six
cases (33.3%) presented a higher risk for DGS/VCFS
recurrence.
Similar situations have been observed in other studies
where increases in chromosomal anomalies have been
found in spermatozoa from transmitting fathers: 15q11q13
deletions in spermatozoa from Prader-Willi syndrome
fathers [35], chromosome 21 disomies in spermatozoa
from Down syndrome fathers [37], sex chromosomes
disomies in spermatozoa from fathers with descendants
affected by Turner syndrome [38] and Klinefelter syn-
drome [39]. Although the number of DGS/VCFS fathers
studied in this work is limited and the anomaly increases
observed are moderate, a comprehensive analysis of the
literature suggest that increases in 22q11.2 anomalies
could reach clinical relevance. Actually, the risk to gen-
erate deletions of these individuals was estimated to be
twice the estimated risk in the control population (odds
ratio 2.03-fold). Accordingly, these individuals should
be considered at risk of transmitting DGS/VCFS to their
descendants. We do believe that, in DGS/VCFS families
with a 22q11.2 deletion transmitted by the father, the
screening of sperm anomalies in the 22q11.2 region
using sperm FISH should be taken into account to gather
information that can help in the genetic reproductive
counseling of families. The detection of higher rates of
deletions in father spermatozoa should be an indication
for a prenatal diagnosis.
Concerning the origin of the increased amount of dele-
tions in these two fathers, although some authors have
Table 2 Determination of the parental origin in eight DGS families: father (F), mother (M) and affected son (S)
CASES D22S1638 D22S1648 D22S264 D22S311 D22S303 PARENTAL ORIGIN
DG1F 114/116 174/174 185/195 251/251 220/222
PATERNAL
DG1M 116/116 174/174 195/195 250/256 222/223
DG1S 116 174 195 256 220/223
DG2F 116/116 170/172 195/203 250/250 212/222
PATERNAL
DG2M 116/116 172/172 201/201 250/257 212/222
DG2S 116 172 201 257 222/222
DG3F 99/105 174/178 193/199 256/256 220/223
PATERNAL
DG3M 116/116 174/174 193/199 256/259 222/224
DG3S 116 174 193 259 220/224
DG5F 116/120 174/174 195/201 250/256 224/225
PATERNAL
DG5M 116/118 174/174 188/203 256/256 224/226
DG5S - 174 203 256 224/226
DG6F 105/116 174/174 187/191 250/250 222/222
MATERNAL
DG6M 109/109 173/178 185/193 250/254 222/222
DG6S 116 174 191 250 222/222
DG7F 109/120 174/174 185/199 250/250 222/224
PATERNAL
DG7M 116/114 174/174 199/205 254/257 212/224
DG7S 116 174 199 254 212/224
DG8F 114/114 174/174 187/199 252/256 213/223
PATERNAL
DG8M 109/116 174/174 199/201 250/256 223/225
DG8S 116 174 199 256 223/223
DG9F 116/116 174/174 199/201 250/256 212/222
MATERNAL
DG9M 111/122 170/171 187/191 250/254 222/222
DG9S 116 174 201 256 212/222
Informative microsatellites are indicated in bold.
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genomic disorders [26-28], no predisposing haplotypes
have yet been described for DGS/VCFS. Nevertheless, it
is reasonable to think about the possible existence of a
different LCR22s architecture in risky DGS/VCFS fathers,
specifically affecting those LCRs mostly involved in the
formation of deletions (LCR22-2 and LCR22-4). Baumer
et al. suggested that variations in the number and position
of LCRs involved in DGS/VCFS may result in higher
rates of unequal crossing-over [40]. Another possible
explanation comes from the influence of allelic variation
at the PRDM9 locus on the 22q11.2 mutation rate. In this
regard, Alemany-Schmidt et al. have recently described a
higher frequency of the PRDM9 A allele in a small popula-
tion of transmitting DGS/VCFS individuals suggesting a
link between PRDM9 allelic variation and NAHR events
[31]. However, other authors have failed to identify this
association [30]. Moreover, the description of PRDM9
capacity for recognizing consensus sequences located
within the LCRs, has also driven the suggestion that the
activity of PRDM9 depends on the number of bindingmotifs and the presence of specific SNPs within the LCR
sequences [29,41].
In any case, further work needs to be done to establish
the genetic factors that promote NAHR events in indi-
viduals with an increased risk of transmitting DGS/
VCFS. This is an important task for the future that we
have already embarked on, studying the LCR22s archi-
tecture using fiber-FISH strategies [42]. We envisage
that this approach would allow the establishment of a
direct relationship between specific LCR haplotypes and
increased rates of NAHR in spermatozoa.
Regarding the NAHR mechanisms of the formation of
reorganizations in the 22q11.2 region, the results obtained
so far by our group have shown a predominant inter-
chromatid NAHR in the 22q11.2 region of control donors
[36] in agreement with other authors which established that
most cases of DGS/VCFS are due to inter-chromosomal
recombination [33,34]. In the present work, although a
higher frequency of 22q11.2 deletions was detected in
DGS/VCFS fathers compared with the frequency of
duplications, the del:dup ratio in six out of nine DGS/
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major inter-chromatid NAHR events. In the remaining
three DGS/VCFS fathers, we found a significant increase in
deletions versus duplications and, hence, a preponderance
of intra-chromatid NAHR. Importantly, two of them were
classified as individuals at risk. In fact, we have described
similar results in sperm-FISH studies in Prader-Willi syn-
drome fathers [35], i.e. a major inter-chromatid NAHR in
control donors and a major intra-chromatid NAHR that
causes higher rates of 15q11q13 deletions in risky fathers.
Many changes and structural rearrangements in the
chromatin structure take place during pre-meiotic, mei-
otic, and post-meiotic stages of spermatogenesis. These
rearrangements involve the formation of double-strand
breaks (DSBs) which could be a source of genomic
instability along spermatogenesis [43,44]. In this way,
the intra-chromatid NAHR events may occur before
meiosis what would give rise to germ cell mosaicism,
thus increasing the chance of transmitting a deletion
[40,45]. Indeed, germ line mosaicism has been proposed
not only as the origin of genomic disorders [16,17,46,47],
but also for other syndromes such as Down syndrome
[48-50], suggesting that germ line mosaicism underlies the
occurrence of many genetic diseases. Intra-chromatid
NAHR arising during or after meiosis would be also likely
to occur and would raise the deletion rates in sperm.
Therefore, although the underlying mechanism remains
elusive, it seems that the major genomic instability at
LCR22s in risky DGS/VCFS fathers preferentially promote
intra-chromatid NAHR events that could occur along all
the entire spermatogenic process. In the presence of risky
haplotypes, the formation of sperm deletions by other
DSB repair systems, like non-homologous end joining
(NHEJ) or fork stalling and template switching (FoSTeS)
should be also considered [5].
Conclusions
This study demonstrated an increased risk of transmitting
DGS/VCFS in some men due to higher rates of deletions
in spermatozoa. Although we are aware of the limitations
of the sample size and that further work needs to be done,
results deserve to be taken into consideration and the
screening of 22q11.2 deletions in spermatozoa should be




Semen samples were obtained from nine DGS/VCFS
fathers aged between 30 and 48 years. All subjects were
normozoospermic and showed normal karyotyes. Per-
ipheral blood samples were collected from eight out of
the nine DGS/VCFS families in EDTA-containing tubes
(Family DG4 did not provide blood samples). Each familyprovided blood samples from the affected offspring and
from the first-degree relatives (parents). To our know-
ledge, none of them had been exposed to genotoxic
agents, and no history of chemotherapy, radiotherapy or
chronic illness was recorded.
Parents gave their informed consent in writing to par-
ticipate in the study and the protocols were approved by
the Institutional Ethics Commitees of the two institu-
tions collaborating in this study (Universitat Autònoma
de Barcelona and Hospital Sant Joan de Déu, Barcelona,
Spain).
Fluorescence in situ hybridization on sperm
Semen samples were processed as described previously
by our group; details of sperm fixation, nuclear deconden-
sation and FISH protocol have been described elsewhere
[51]. Briefly, the sperm fraction was resuspended in hypo-
tonic solution (0.075 M KCl) for 30 minutes at 37°C and
fixed in methanol:acetic acid (3:1) solution. Spermatozoa
were spread on a slide and kept at -20°C. Prior to
hybridization, sperm nuclei were decondensed by slide
incubation at 37°C in Tris buffer containing 25 mmol/ml
dithiothreitol and 1% Triton X-100 from 5 to 10 minutes.
To determine the frequency of deletions and duplications
in the critical 22q11.2 region, the following probe combin-
ation was used (Figure 4): 1) locus-specific (LSI) probe for
TUPLE1 localized inside the critical region at the 22q11.2
sub-band (Spectrum Orange; Abbott Molecular), 2) LSI
probe for ARSA localized outside the critical region at the
22q13 sub-band (Spectrum Green; Abbott Molecular) and
3) centromeric probe recognizing the D6Z1 locus of
chromosome 6 (CEP6, Spectrum Aqua; Abbot Molecular).
LSI ARSA was used to discriminate between nullisomy/
disomy 22 and 22q11.2 deletion/duplication genotypes,
respectively, while the CEP6 probe was used as a ploidy
control.
Analyses were carried out using an Olympus BX60
epifluorescence microscope equipped with a triple-band
pass filter and specific filters for Aqua, FITC and Cy3. A
minimum of 10,000 sperm nuclei were analyzed for every
single father in two independent FISH experiments, apply-
ing strict assessment criteria [35].
Statistical analysis
Data were analyzed using SPSS 15.0 software (SPSS Inc.;
Chicago IL, USA) under the advice of the statistical ser-
vice of the Universitat Autònoma de Barcelona. To avoid
false positives due to the high number of spermatozoa
analyzed per subject, differences were considered to be
statistically significant when P < 0.01.
To assess the susceptibility in generating deletions and
duplications, the mean frequency of 22q11.2 deletions,
duplications and the sum of deletions and duplications
(del + dup) of DGS/VCFS fathers were compared with the
Figure 4 FISH design. A. Probe combination: LSI TUPLE1 at 22q11.2, Spectrum Orange; LSI ARSA at 22q13, Spectrum Green; and CEP6 at D6Z1
locus, Spectrum Aqua. B. Representative images of spermatozoa with normal (B1), deleted (B2) and duplicated (B3) genotypes.
Table 3 Microsatellite markers used to determine the parental origin
Microsatellite Position Primers Labelling Lenght (bp) Annealing temperature
D22S1638a 22q11.21 F: GACAACAGCAAATTGCACATT HEX 93 55°C
R: TCACGCCACTACCCTCCAG
D22S1648a 22q11.21 F: CAGATGCTTCAGGAGAAGTG HEX 152 50°C
R: AGTTGTCAGATGCCTAAGAGA
D22S264a 22q11.21 F: ATTAACTCATAAAGGAGCCC HEX 190-198 56°C
R: CACCCCACCAGAGGTATTCC
D22S311a 22q11.21 F: GCTAGTGTGAGATAACGAAGCC 6-FAM 262 63°C
R: TTTTTGTATTTTTAGTAGAGACGG
D22S303b 22q11.22 F: AGGACCTCAGACTGGTCAGTC 6-FAM 220-233 56°C
R: CTCCCATGAGAAGGTACACTCC
aMicrosatellites inside the deleted region.
bMicrosatellite outside the deleted region.
Table shows the forward (F) and reverse (R) primers, the 5′ labelling in the forward primers, the size of the amplified markers and their chromosomal position.
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using a Mann-Whitney test. Next, the frequencies of dele-
tions, duplications and del + dup of every single father
were compared with the basal frequencies observed in the
control population using a Chi-square test. Additionally,
Spearman correlations between the frequency of deletions,
duplications and del + dup and the age of DGS/VCFS
fathers were performed.
To assess the participation of inter-chromatid and/or
intra-chromatid NAHR in the generation of anomalies,
three comparisons were performed. A Spearman correl-
ation test of 22q11.2 deletion and duplication frequencies
was performed in DGS/VCFS fathers. In order to analyze
whether the mean frequency of deletions was different
from that of duplications, a Wilcoxon test and Chi-square
test were performed at the population and individual level,
respectively.Microsatellite analysis
To determine the parental origin of the deleted chromo-
some in the affected children, genomic DNA was isolated
from 3 mL of peripheral blood samples collected in EDTA-
containing tubes using the Gentra Puregene Blood kit
(QUIAGEN Inc.) following the manufacturer’s instructions.
Five microsatellite markers distributed inside (D22S1638,
D22S1648, D22S264, D22S311) and outside (D22S303) the
deleted region were genotyped in every single DGS/VCFS
family (Figure 1B; Table 3).
The microsatellite markers were amplified by PCR using
dye-labeled primers (HEX or 6-FAM) and following
standard procedures. PCR amplifications were performed
in a reaction mixture containing 40-90 ng of genomic
DNA, 25 pmol of each primer (Roche), 2.5 mM of each
dNTP (Applied Biosystems), 25 mM MgCl2 (Applied
Biosystems), 10x PCR buffer II (Applied Biosystems) and
1U AmpliTaq Gold DNA polymerase (Applied Biosys-
tems). Amplifications were performed as follows: 94°C for
10 min; 35 cycles of 94°C for 30 s, an appropriate anneal-
ing temperature for 30 s, and 72°C for 35 s; and a final
extension step of 72°C for 12 min.
Products were analyzed by capillary electrophoresis on a
genetic analyzer (ABI3130 XL, Applied Biosystems) using
Peak Scanner software, version 2.0 (Applied Biosystems).
Sperm FISH and microsatellite analyses were done in
a blinded manner and the results were compared only at
the end of the entire experiment.Abbreviations
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